{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:06:51Z","timestamp":1789056411731,"version":"build-2803163510"},"reference-count":89,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002808","name":"Carlsberg Foundation","doi-asserted-by":"publisher","award":["CF17-0129"],"award-info":[{"award-number":["CF17-0129"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002808","name":"Carlsberg Foundation","doi-asserted-by":"publisher","award":["CF20-0424"],"award-info":[{"award-number":["CF20-0424"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["101041231"],"award-info":[{"award-number":["101041231"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF21OC0071259"],"award-info":[{"award-number":["NNF21OC0071259"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R238-2016-3349"],"award-info":[{"award-number":["R238-2016-3349"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["0242-00009B"],"award-info":[{"award-number":["0242-00009B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["8056-00010B"],"award-info":[{"award-number":["8056-00010B"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["4352-00003B"],"award-info":[{"award-number":["4352-00003B"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009512","name":"Agnes and Poul Friis Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omta.2026.201787","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:41:42Z","timestamp":1781714502000},"page":"201787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["AAV vector production in suspension cells using PEI transfection and sodium butyrate with orthogonal assessment of function and quality"],"prefix":"10.1016","volume":"34","author":[{"given":"Sujan","family":"Ravendran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Famm\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya Graham","family":"Noer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Wisbech","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna Steengaard","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lee Schneller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie Rahbek","family":"Dorset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas Holst","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs Marie Julie","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didde","family":"Haslund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Louise S.","family":"Revenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine H.","family":"Mogensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarne Kuno","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob Giehm","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7383-0297","authenticated-orcid":false,"given":"Rasmus O.","family":"Bak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201787_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2277-9175.98152","article-title":"Viral and nonviral delivery systems for gene delivery","volume":"1","author":"Nayerossadat","year":"2012","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.omta.2026.201787_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105834","article-title":"Viral and non-viral vectors in gene therapy: current state and clinical perspectives","volume":"118","author":"Geng","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omta.2026.201787_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/bit.26461","article-title":"Advancements in the design and scalable production of viral gene transfer vectors","volume":"115","author":"Sharon","year":"2018","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omta.2026.201787_bib4","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/s41591-024-03035-1","article-title":"Enhancing pediatric access to cell and gene therapies","volume":"30","author":"Mackall","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201787_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1538-7836.2006.02220.x","article-title":"Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy","volume":"5","author":"Vandendriessche","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.omta.2026.201787_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41434-022-00363-0","article-title":"Changing trends in the development of AAV-based gene therapies: a meta-analysis of past and present therapies","volume":"30","author":"Burdett","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201787_bib7","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/mt.2012.194","article-title":"Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union","volume":"20","author":"Yl\u00e4-Herttuala","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201787_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/d41573-021-00017-7","article-title":"The clinical landscape for AAV gene therapies","volume":"20","author":"Kuzmin","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omta.2026.201787_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/biology12020186","article-title":"AAV Engineering for Improving Tropism to the Central Nervous System","volume":"12","author":"Ghauri","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.omta.2026.201787_bib10","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1056\/NEJMoa2307159","article-title":"Fidanacogene Elaparvovec for Hemophilia B - A Multiyear Follow-up Study","volume":"392","author":"Rasko","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201787_bib11","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa2302982","article-title":"Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B","volume":"391","author":"Cuker","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201787_bib12","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1056\/NEJMoa2400521","article-title":"DB-OTO Gene Therapy for Inherited Deafness","volume":"394","author":"Valayannopoulos","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201787_bib13","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1182\/blood-2023-188963","article-title":"One Year Follow-up on the First Patient Treated with Nula-Cel: An Autologous CRISPR\/Cas9 Gene Corrected CD34+ Cell Product to Treat Sickle Cell Disease","volume":"142","author":"Shyr","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201787_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf2444","article-title":"Development of beta-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease","volume":"13","author":"Lattanzi","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omta.2026.201787_bib15","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1158\/2159-8290.CD-24-0102","article-title":"CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma","volume":"14","author":"Pal","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omta.2026.201787_bib16","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1093\/hmg\/ddv451","article-title":"Progress and challenges in viral vector manufacturing","volume":"25","author":"van der Loo","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omta.2026.201787_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.omtm.2018.01.002","article-title":"Pharmacology of Recombinant Adeno-associated Virus Production","volume":"8","author":"Penaud-Budloo","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201787_bib18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.gt.3302233","article-title":"Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors","volume":"11","author":"Flotte","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201787_bib19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.omtm.2023.05.004","article-title":"A novel dual-plasmid platform provides scalable transfection yielding improved productivity and packaging across multiple AAV serotypes and genomes","volume":"29","author":"van Lieshout","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201787_bib20","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201787_bib21","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.xphs.2021.03.024","article-title":"Manufacturing Challenges and Rational Formulation Development for AAV Viral Vectors","volume":"110","author":"Srivastava","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.omta.2026.201787_bib22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa2214084","article-title":"Gene Therapy in Patients with the Crigler-Najjar Syndrome","volume":"389","author":"D\u2019Antiga","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201787_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.omtm.2023.06.010","article-title":"Goody two plasmids: An optimized transient transfection system for AAV vector production","volume":"30","author":"Moreno Velasquez","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201787_bib24","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S1474-4422(23)00313-7","article-title":"Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial","volume":"22","author":"Shieh","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omta.2026.201787_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1001263","article-title":"rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis","volume":"13","author":"Shen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omta.2026.201787_bib26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/hum.2010.202","article-title":"Good manufacturing practice production of self-complementary serotype 8 adeno-associated viral vector for a hemophilia B clinical trial","volume":"22","author":"Allay","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201787_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.omtm.2018.11.004","article-title":"Scalable Production of AAV Vectors in Orbitally Shaken HEK293 Cells","volume":"13","author":"Blessing","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201787_bib28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/mt.2015.187","article-title":"Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector","volume":"24","author":"Grieger","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201787_bib29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0042-6822(66)90291-1","article-title":"A small virus associated with the simian adenovirus SV11","volume":"29","author":"Archetti","year":"1966","journal-title":"Virology"},{"key":"10.1016\/j.omta.2026.201787_bib30","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1073\/pnas.81.20.6466","article-title":"Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells","volume":"81","author":"Hermonat","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201787_bib32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/d41586-023-00088-z","article-title":"Facing inflation: lab heads tighten supplies budgets","volume":"613","author":"Woolston","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201787_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jbiotec.2016.04.028","article-title":"Comparative study of polyethylenimines for transient gene expression in mammalian HEK293 and CHO cells","volume":"227","author":"Delafosse","year":"2016","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.omta.2026.201787_bib34","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1089\/hum.2009.064","article-title":"Transient transfection methods for clinical adeno-associated viral vector production","volume":"20","author":"Wright","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201787_bib35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/pharmaceutics7030152","article-title":"Highly Effective Non-Viral Antitumor Gene Therapy System Comprised of Biocompatible Small Plasmid Complex Particles Consisting of pDNA, Anionic Polysaccharide, and Fully Deprotected Linear Polyethylenimine","volume":"7","author":"Koyama","year":"2015","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omta.2026.201787_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10616-012-9483-9","article-title":"PEI\/DNA formation affects transient gene expression in suspension Chinese hamster ovary cells via a one-step transfection process","volume":"65","author":"Xie","year":"2013","journal-title":"Cytotechnology"},{"key":"10.1016\/j.omta.2026.201787_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202200450","article-title":"Increased recombinant adeno-associated virus production by HEK293 cells using small molecule chemical additives","volume":"18","author":"Scarrott","year":"2023","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.omta.2026.201787_bib38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.omtm.2020.06.004","article-title":"Creation of a High-Yield AAV Vector Production Platform in Suspension Cells Using a Design-of-Experiment Approach","volume":"18","author":"Zhao","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201787_bib39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0092-8674(78)90305-7","article-title":"Sodium butyrate inhibits histone deacetylation in cultured cells","volume":"14","author":"Candido","year":"1978","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201787_bib40","doi-asserted-by":"crossref","first-page":"7631","DOI":"10.1093\/nar\/11.21.7631","article-title":"Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate","volume":"11","author":"Gorman","year":"1983","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omta.2026.201787_bib41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/hgtb.2019.031","article-title":"Two-Dimensional Droplet Digital PCR as a Tool for Titration and Integrity Evaluation of Recombinant Adeno-Associated Viral Vectors","volume":"30","author":"Furuta-Hanawa","year":"2019","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omta.2026.201787_bib42","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3389\/fmicb.2019.01570","article-title":"Accurate Quantification and Characterization of Adeno-Associated Viral Vectors","volume":"10","author":"Dobnik","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.omta.2026.201787_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101419","article-title":"Impact of DNase digestion on titer measurements of engineered adeno-associated virus serotypes","volume":"33","author":"Zin","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201787_bib44","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 beta-globin gene targeting in human haematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201787_bib45","doi-asserted-by":"crossref","first-page":"22657","DOI":"10.1021\/acsomega.4c10900","article-title":"Improving AAV Production Yield and Quality for Different Serotypes Using Distinct Processing Methods","volume":"10","author":"Khaparde","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.omta.2026.201787_bib46","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1089\/hum.2010.107","article-title":"Efficient serotype-dependent release of functional vector into the culture medium during adeno-associated virus manufacturing","volume":"21","author":"Vandenberghe","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201787_bib47","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1089\/hgtb.2012.105","article-title":"Comparison of adeno-associated virus serotypes and delivery methods for cardiac gene transfer","volume":"23","author":"Fang","year":"2012","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omta.2026.201787_bib48","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201787_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311033","article-title":"Quantification of Empty, Partially Filled and Full Adeno-Associated Virus Vectors Using Mass Photometry","volume":"24","author":"Wagner","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omta.2026.201787_bib50","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/mt.2015.123","article-title":"Riboswitch-mediated Attenuation of Transgene Cytotoxicity Increases Adeno-associated Virus Vector Yields in HEK-293 Cells","volume":"23","author":"Strobel","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201787_bib51","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/bit.28068","article-title":"Only a small fraction of cells produce assembled capsids during transfection-based manufacturing of adeno-associated virus vectors","volume":"119","author":"Dash","year":"2022","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omta.2026.201787_bib52","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/jvi.71.3.1897-1905.1997","article-title":"Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products","volume":"71","author":"Vincent","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201787_bib53","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1089\/10430349950017563","article-title":"Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system","volume":"10","author":"Hermens","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201787_bib54","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/bit.26367","article-title":"Intracellular characterization of Gag VLP production by transient transfection of HEK 293 cells","volume":"114","author":"Cervera","year":"2017","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omta.2026.201787_bib55","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jviromet.2013.10.038","article-title":"Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery","volume":"196","author":"Chahal","year":"2014","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.omta.2026.201787_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202300051","article-title":"Production of adeno-associated viral vector serotype 6 by triple transfection of suspension HEK293 cells at higher cell densities","volume":"18","author":"Mo\u00e7o","year":"2023","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.omta.2026.201787_bib57","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omta.2026.201787_bib58","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.omtm.2021.04.006","article-title":"Mechanistic model for production of recombinant adeno-associated virus via triple transfection of HEK293 cells","volume":"21","author":"Nguyen","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201787_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2013.9","article-title":"Empty Virions In AAV8 Vector Preparations Reduce Transduction Efficiency And May Cause Total Viral Particle Dose-Limiting Side-Effects","volume":"1","author":"Gao","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201787_bib60","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/biores.2020.0031","article-title":"Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus","volume":"9","author":"Tang","year":"2020","journal-title":"Biores. Open Access"},{"key":"10.1016\/j.omta.2026.201787_bib61","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1038\/s41598-018-23593-y","article-title":"LentiPro26: novel stable cell lines for constitutive lentiviral vector production","volume":"8","author":"Tom\u00e1s","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2026.201787_bib62","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1089\/hum.1995.6.9-1195","article-title":"Use of sodium butyrate to enhance production of retroviral vectors expressing CFTR cDNA","volume":"6","author":"Olsen","year":"1995","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201787_bib63","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1073\/pnas.75.5.2239","article-title":"Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences","volume":"75","author":"Vidali","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201787_bib64","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2144\/03345st02","article-title":"High-yield production of recombinant antibody fragments in HEK-293 cells using sodium butyrate","volume":"34","author":"Gr\u00fcnberg","year":"2003","journal-title":"Biotechniques"},{"key":"10.1016\/j.omta.2026.201787_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202300097","article-title":"Investigating dynamics of lentiviral vector secretion from HEK293T producer cells using a fractionated perfusion system","volume":"19","author":"Timmins","year":"2024","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.omta.2026.201787_bib66","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jviromet.2004.08.017","article-title":"Optimized large-scale production of high titer lentivirus vector pseudotypes","volume":"122","author":"Sena-Esteves","year":"2004","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.omta.2026.201787_bib67","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1089\/hum.2022.153","article-title":"Process Development of Recombinant Adeno-Associated Virus Production Platform Results in High Production Yield and Purity","volume":"34","author":"Zhao","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201787_bib68","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/bit.10108","article-title":"Fluorescent proteins in animal cells for process development: optimization of sodium butyrate treatment as an example","volume":"77","author":"Hunt","year":"2002","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omta.2026.201787_bib69","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1134\/S1990519X21030020","article-title":"Effect of Sodium Butyrate on Proliferative Signaling Cascades in Sensitive and Resistant to Histone Deacetylase Inhibitors Cells","volume":"15","author":"Gnedina","year":"2021","journal-title":"Cell tissue biol."},{"key":"10.1016\/j.omta.2026.201787_bib70","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.omtm.2023.01.002","article-title":"Production of rAAV by plasmid transfection induces antiviral and inflammatory responses in suspension HEK293 cells","volume":"28","author":"Chung","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201787_bib71","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1038\/sj.onc.1207852","article-title":"Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB","volume":"23","author":"Joseph","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.omta.2026.201787_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2021.02.015","article-title":"NaCl and KCl mediate log increase in AAV vector particles and infectious titers in a specific\/timely manner with the HSV platform","volume":"21","author":"Yu","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201787_bib73","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s10529-007-9441-3","article-title":"High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cells","volume":"29","author":"Hildinger","year":"2007","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.omta.2026.201787_bib74","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1089\/hum.2022.143","article-title":"Direct ITR-to-ITR Nanopore Sequencing of AAV Vector Genomes","volume":"33","author":"Namkung","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201787_bib75","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41434-021-00311-4","article-title":"Rapid characterization of adeno-associated virus (AAV) gene therapy vectors by mass photometry","volume":"29","author":"Wu","year":"2022","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201787_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101499","article-title":"AAV yield, bioactivity, and particle heterogeneity are impacted by genome size and non-coding DNA elements","volume":"33","author":"Blahetek","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201787_bib77","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.gpb.2015.08.002","article-title":"PacBio Sequencing and Its Applications","volume":"13","author":"Rhoads","year":"2015","journal-title":"Genom. Proteom. Bioinform."},{"key":"10.1016\/j.omta.2026.201787_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.32","article-title":"Advanced Characterization of DNA Molecules in rAAV Vector Preparations by Single-stranded Virus Next-generation Sequencing","volume":"4","author":"Lecomte","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omta.2026.201787_bib79","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/hgtb.2015.048","article-title":"Analytical Ultracentrifugation as an Approach to Characterize Recombinant Adeno-Associated Viral Vectors","volume":"26","author":"Burnham","year":"2015","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omta.2026.201787_bib80","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/s41598-024-77378-7","article-title":"Three-dimensional linkage analysis with digital PCR for genome integrity and identity of recombinant adeno-associated virus","volume":"15","author":"Duong","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2026.201787_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2023.115421","article-title":"Separation of full and empty adeno-associated virus capsids by anion-exchange chromatography using choline-type salts","volume":"686","author":"Kurth","year":"2024","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.omta.2026.201787_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101382","article-title":"Size-exclusion chromatography as a multi-attribute method for process and product characterization of adeno-associated virus","volume":"32","author":"Mulagapati","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201787_bib83","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1002\/bit.28412","article-title":"Critical challenges and advances in recombinant adeno-associated virus (rAAV) biomanufacturing","volume":"120","author":"Fu","year":"2023","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omta.2026.201787_bib84","doi-asserted-by":"crossref","first-page":"753","DOI":"10.18609\/cgti.2018.080","article-title":"Establishment of a scalable manufacturing platform for in-silico-derived ancestral adeno-associated virus vectors","volume":"4","author":"Gu","year":"2018","journal-title":"Cell Gene Ther. Insights"},{"key":"10.1016\/j.omta.2026.201787_bib85","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10616-005-5361-z","article-title":"Evaluation of a Serum-free Medium for the Production of rAAV-2 using HeLa Derived Producer Cells","volume":"49","author":"Jenny","year":"2005","journal-title":"Cytotechnology"},{"key":"10.1016\/j.omta.2026.201787_bib86","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.omtm.2020.05.018","article-title":"Methods Matter: Standard Production Platforms for Recombinant AAV Produce Chemically and Functionally Distinct Vectors","volume":"18","author":"Rumachik","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201787_bib87","article-title":"AAV manufacturing for clinical use: Insights on current challenges from the upstream process perspective","volume":"20","author":"Dobrowsky","year":"2021","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"10.1016\/j.omta.2026.201787_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.2","article-title":"Manufacturing of recombinant adeno-associated viral vectors for clinical trials","volume":"3","author":"Cl\u00e9ment","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201787_bib89","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.gt.3300938","article-title":"Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield","volume":"6","author":"Zolotukhin","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201787_bib90","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/hgtb.2011.034","article-title":"Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences","volume":"23","author":"Aurnhammer","year":"2012","journal-title":"Hum. Gene Ther. Methods"}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:12:57Z","timestamp":1789053177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26001229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3117387X26001229"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201787","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV vector production in suspension cells using PEI transfection and sodium butyrate with orthogonal assessment of function and quality","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201787"}}